Table 2.
Characteristics of HAIs occurring after ICU admission
| n = 43 | |||
|---|---|---|---|
| Type of infection | Imported nosocomial | 15 (34.9) | |
| In-ICU acquired nosocomial | 28 (65.1) | ||
| Infection type | Bacterial | 37 (86.0) | |
| Fungal | 5 (11.6) | ||
| Both | 1 (2.3) | ||
| Site of origin | Primary BSI | 14 (32.6) | |
| Pulmonary | 14 (32.6) | ||
| UTI | 9 (20.9) | ||
| Digestive | 4 (9.3) | ||
| CLABSI | 2 (4.7) | ||
| Positive blood samples | 27 (62.8) | ||
| Organism cultured | Gram negative | Pseudomonas aeruginosa | 11 (25.6) |
| Escherichia coli | 4 (9.3) | ||
| Enterobacter cloacae | 3 (7.0) | ||
| Klebsiella pneumoniae | 2 (4.7) | ||
| Enterobacter aerogenes | 1 (2.3) | ||
| Stenotrophomonas maltophilia | 1 (2.3) | ||
| Comamonas testosteroni | 1 (2.3) | ||
| Mycoplasma pneumoniae | 1 (2.3) | ||
| Gram positive | Enterococcus faecium | 7 (16.3) | |
| Staphylococcus aureus | 3 (7.0) | ||
| Enterococcus faecalis | 2 (4.7) | ||
| Streptococcus spp. | 1 (2.3) | ||
| Fungi | Aspergillus spp. | 3 (7.0) | |
| Candida glabrata | 2 (4.7) | ||
| Candida albicans | 1 (2.3) | ||
| Time from ICU admission to infection (days) | 4 [1, 8] | ||
| Time from etoposide to infection (days) | 5 [0, 9] |
Values are given in N (%) or median [IQR]
BSI bloodstream infection, CLABSI central line-associated blood stream infection, UTI urinary tract infection